All stocks / APTN
ADAPTIN BIO, INC. APTN
Adaptin BIO (APTN): a late 10-K notice in April 2026 and the latest annual figures in plain language. Each fact links to its SEC filing.
Market listing
- Full name
- ADAPTIN BIO INC.
- Market tier
- OTCQB
- Trading status
- Active
- Last trade
- Sep 07
- Website
- ir.adaptinbio.com/
News headlines
The financial report, and what it means
Annual figures to 2025-12-31- Net loss
- ($5,167,569)
It spends more than it earns
Under strainThe company lost $5.2 million in the year. It reported no sales.
- Cash and cash equivalents
- $459,174
- Net cash used in operating activities
- ($4,777,892)
The cash could run out soon
Under strainIt had $459,174 in the bank and used about $398,158 a month. At that pace the money lasts about 1 months unless it borrows or sells more shares.
- Total assets
- $619,159
- Total liabilities
- $2,108,555
It owes more than it owns
Under strainEverything the company owns adds up to $619,159. Its debts and unpaid bills add up to $2.1 million. That is about $3.41 owed for every $1 owned.
What this adds up to
3 of 3 checks show strain. It spends more than it earns. The cash could run out soon. It owes more than it owns. These are facts from the company's own reports, not a recommendation.
Signals
Estimated float about 9,261,601 shares as of 2026-11-12: 9,261,601 outstanding minus 0 held by 0 reporting insider(s).
Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record
Filed NT 10-K on 2026-04-01: notice that a periodic report is late.
Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record
Shares outstanding
Source: SEC filingsPrice chart
Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets
Recent filings
| 2026-11-13 | 10-Q | QUARTERLY REPORT |
| 2026-09-10 | 424B3 | PROSPECTUS |
| 2026-09-09 | EFFECT | |
| 2026-08-28 | S-1 | REGISTRATION STATEMENT |
| 2026-08-25 | 8-K | CURRENT REPORT |
| 2026-08-25 | 424B3 | PROSPECTUS SUPPLEMENT |
| 2026-08-20 | 424B3 | PROSPECTUS SUPPLEMENT |
| 2026-08-13 | 10-Q | QUARTERLY REPORT |
| 2026-07-22 | EFFECT | |
| 2026-07-21 | POS AM | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 |
| 2026-06-22 | D/A | |
| 2026-06-12 | 10-K/A | AMENDMENT NO. 1 TO FORM 10-K |
Common questions about APTN
Does APTN file reports with the SEC?
Yes. Adaptin BIO files with the SEC under company number 0001938571. The most recent filing we hold is a 10-Q dated 2026-11-13.
Source recordHow many APTN shares are outstanding?
9,261,601 shares as of 2026-11-12, as reported to the SEC.
Source recordHas APTN filed reports late?
Yes. In the last 12 months it filed 1 late-filing notice, most recently a NT 10-K on 2026-04-01. A notice means a report was not ready on time; check whether the report followed.
Source recordIs Adaptin BIO making money?
The company lost $5.2 million in the year. It reported no sales. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)
Source record